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Recent papers suggest that TMC1 and TMC2 constitute the ion channels mediating hearing and
balance. Kurima et al. (2015) now show these proteins are expressed in the right place and at the
right time, bringing us closer to definitive identification.More than 50 years ago, Georg von Be´k-
e´sy, who received the Nobel Prize for
elucidation of frequency tuning in the co-
chlea, hinted at the molecular basis of
what he called ‘‘the finalmechanical trans-
former’’ for converting sound into a neural
signal. This is nowunderstood to be a spe-
cific ion channel, remarkably fast (opening
in microseconds) and remarkably sensi-
tive (activated by sub-nanometer move-
ments), located at the tips of mechano-
sensitive stereocilia of inner-ear hair
cells.Much is known about the biophysics
of this transduction channel (Fettiplace
and Kim, 2014; Kawashima et al., 2015).
It passes metal and organic cations up to
1.2 nm in diameter and has a high
conductance ranging from 80 to 320 pS
(Pan et al., 2013; Fettiplace and Kim,
2014). A channel is opened when pulled
on by filamentous tip links that run be-
tween adjacent stereocilia, and channel
opening involves a large conformational
change of 4 nm (Fettiplace and Kim,
2014). But 50 years later, the channel’s
molecular identity remains uncertain. A
new report from the Kachar, Griffith, and
Holt laboratories (Kurima et al., 2015)
nowgets us closer to a clear identification.
Positional cloning of deafness genes in
humans and mice has been exceptionally
productive in revealing molecular compo-
nents of the transduction machinery in
hair cells. One such gene, named trans-
membrane channel-like 1 (TMC1) for its
six to ten transmembrane domains, is
mutated both in dominant (DFNA36) and
recessive (DFNB7 and DFNB11) forms of
human hereditary deafness, and in the
deafness and Beethoven mouse mutants
(Kurima et al., 2002). The TMCgene familycomprises eight members in mammals.
Despite the name, the function of the
TMC1 protein is not clear; in particular,
the possibility that TMC1 is a transduction
channel was called into question by the
persistence of the transduction current
in neonatal cochlear hair cells of mutant
mice lacking TMC1 (see Kawashima
et al., 2015 for review). However, Kawa-
shima et al. (2011) showed that TMC2 is
also present in these cells, at least tran-
siently, so it might compensate for loss
of TMC1. By testing both single and dou-
ble knockouts, they found that one or the
other TMC is sufficient for hair cell func-
tion. Tmc2 expression in cochlea then
goes down, creating an absolute require-
ment for TMC1 at later stages.
This requirement satisfied one criterion
for identification of a mechanically-gated
transduction channel (Christensen and
Corey, 2007), but meeting others has
been more difficult. A second criterion—
that the candidate protein, when heterolo-
gously expressed, should produce a me-
chanically-evoked current—is unlikely to
be met until all components of the trans-
duction apparatus are identified and
co-expressed.A thirdcriterion is that ahet-
erologously expressed candidate should
produce a conductance with properties
similar to the native transduction channel.
No group has expressed a TMC protein
in a cell line and convincingly evoked a
current because TMCs apparently don’t
reach the plasma membrane without a
chaperone. However, an alternate crite-
rion, that certain mutations of a candidate
gene should change the selectivity or
conductance of the transduction current
in hair cells, has been met in severalCell Reports 12, Seways. First, mice expressing just Tmc1
or just Tmc2 have transduction channels
with either low or high conductance and
low or high Ca2+ permeability (Pan et al.,
2013; Kim et al., 2013, Beurg et al., 2014).
Second, the Beethoven mouse has a
missense mutation (M412K) in a region
predicted to be transmembrane and has
transduction currents with even lower
conductance and lower Ca2+ permeability
(Pan et al., 2013). Although it is possible
that the channel pore is formed by another
protein and that TMCs are accessory sub-
units that affect conductance, the simplest
hypothesis is that TMCs form the pore.
Still, other criteria must be met (Chris-
tensen and Corey, 2007), and here the
new work contributes substantially. The
candidate channel must be expressed
in the right place at the right time. For
cochlear hair cells, protein should be
located where physiological experiments
have shown transduction channels to
be—at the tips of stereocilia. Kawashima
et al. (2011) previously expressed GFP-
tagged TMC1 in hair cells, and Beurg
et al. (2015) used an antibody to localize
TMC1. Both showed localization near
stereocilia tips, but neither study was
comprehensive. Kurima et al. (2015)
have now created two types of BAC
transgenic mouse lines, one producing
TMC1 fused to mCherry under the Tmc1
promoter and one with TMC2 fused to
GFP under the Tmc2 promoter. With
spectacular resolution, the tagged TMCs
were found exactly where expected.
Localization is diffuse in early neonatal
stereocilia but still concentrated at the
stereocilia tips and is clearly restricted to
tips at later ages. Ca2+ imaging has shownptember 8, 2015 ª2015 The Authors 1531
that the tallest stereocilia, at least in
mammals, do not have transduction
channels (Fettiplace and Kim, 2014), and
the tagged TMCs were only rarely seen
in the tallest stereocilia. In a double-
knockout background, the BAC trans-
genes rescued hearing, indicating that
the fluorescently-tagged TMCs are func-
tional and properly localized. Immunoflu-
orescence with antibodies to TMCs inde-
pendently confirmed the localization.
With BAC rescue, the time course of
protein expression under the normal pro-
moters can be followed. As expected,
fluorescent TMC2 appeared first in the
cochlea at postnatal day 2 (P2), when
cochlear hair cells are first mechanosensi-
tive, and TMC1 followed a few days later
with full expression by P7. TMC2 then dis-
appeared by P10, a time when cochlear
function is known to require TMC1. In the
vestibular system, both TMC1 and TMC2
persisted, consistent with a lack of vestib-
ular phenotype in mice or humans with
mutation of just TMC1. The exquisite
resolution also allowed the authors to ask
whether TMC1 associates with TMC2 in
a molecular complex. They found that
TMC1-mCherry fluorescent puncta ap-
pearedwithin 30 nmof TMC2-GFP puncta1532 Cell Reports 12, September 8, 2015 ª2at levels higher than chance, consistent
with a heteromeric channel andwith the in-
termediate single-channel conductances
often found in wild-type animals (Pan
et al., 2013). Because this could result
from TMC concentration at stereocilia
tips, it will be important to demonstrate
biochemical interaction. Finally, the locali-
zation clearly demonstrates that TMC1
and TMC2 are proteins of the plasma
membrane, not restricted to the ER.
Much work remains. Localization with
immunogold electron microscopy would
be welcome, to localize TMCs within
nanometers of the tip-link filaments that
are thought to pull on transduction chan-
nels. X-ray crystal structure would eluci-
date the stoichiometry of TMC associa-
tion and might reveal a central pore.
Finally, there are additional components
of the transduction apparatus, such as
protocadherin-15, TMHS/LHFPL5, and
TMIE. Full understanding will require
both biochemical and structural assembly
of this molecular jigsaw puzzle.REFERENCES
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